National Vaccine
Information Center

Your Health. Your Family. Your Choice.

MedAlerts Home
Search Results

From the 9/17/2021 release of VAERS data:

Found 3,700 cases where Vaccine targets COVID-19 (COVID19) and Symptom is Myocarditis



Case Details

This is page 8 out of 370

Result pages: prev   1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17   next


VAERS ID: 1147032 (history)  
Form: Version 2.0  
Age: 19.0  
Sex: Male  
Location: Virginia  
Vaccinated:2021-03-25
Onset:2021-03-28
   Days after vaccination:3
Submitted: 0000-00-00
Entered: 2021-03-30
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
COVID19: COVID19 (COVID19 (PFIZER-BIONTECH)) / PFIZER/BIONTECH - / 1 - / IM

Administered by: Private       Purchased by: ?
Symptoms: Acute left ventricular failure, Blood creatine phosphokinase increased, Cardiogenic shock, Chest pain, Dizziness, Dyspnoea, Ejection fraction, Fatigue, Muscle necrosis, Myocarditis, Nausea, Pain, Pulmonary oedema, Pyrexia, Respiratory failure, Troponin increased, Vision blurred
SMQs:, Rhabdomyolysis/myopathy (narrow), Cardiac failure (narrow), Anaphylactic reaction (broad), Acute pancreatitis (broad), Neuroleptic malignant syndrome (narrow), Myocardial infarction (narrow), Anticholinergic syndrome (broad), Shock-associated circulatory or cardiac conditions (excl torsade de pointes) (narrow), Torsade de pointes, shock-associated conditions (broad), Hypovolaemic shock conditions (broad), Toxic-septic shock conditions (broad), Anaphylactic/anaphylactoid shock conditions (broad), Hypoglycaemic and neurogenic shock conditions (broad), Acute central respiratory depression (narrow), Pulmonary hypertension (broad), Guillain-Barre syndrome (broad), Gastrointestinal nonspecific symptoms and therapeutic procedures (narrow), Haemodynamic oedema, effusions and fluid overload (narrow), Glaucoma (broad), Cardiomyopathy (broad), Lens disorders (broad), Retinal disorders (broad), Vestibular disorders (broad), Hypersensitivity (broad), Respiratory failure (narrow), Drug reaction with eosinophilia and systemic symptoms syndrome (broad), Hypoglycaemia (broad), Hypokalaemia (broad), Immune-mediated/autoimmune disorders (broad)

Life Threatening? No
Birth Defect? No
Died? No
Permanent Disability? No
Recovered? No
Office Visit? No
ER Visit? No
ER or Doctor Visit? Yes
Hospitalized? Yes, 2 days
   Extended hospital stay? No
Previous Vaccinations:
Other Medications: Cetirizine 10mg PO daily Cyclobenzaprine 10mg PO Q8H PRN Montelukast 10mg PO daily
Current Illness: None
Preexisting Conditions: None
Allergies: Ketorolac
Diagnostic Lab Data: 3/28 0909 CPK 388 U/L 3/28 1431 CPK 2334 U/L 3/29 0803 CPK 1273 U/L 3/28 0440 Troponin (T) 1438 ng/L 3/28 0738 Troponin(T) 2118 ng/L 3/28 1814 Troponin(T) 3064 ng/L 3/29 0527 Troponin(T) 2644 ng/L 3/30 0800 Troponin(T) 2824 ng/L 3/28 0900 Echo EF 38%
CDC Split Type:

Write-up: Pt reports generalized body aches, fatigue, fever 3/26, one day after receiving vaccine. Evaluated at ED 3/28, received Ketorolac and was discharged. While in parking lot, patient experienced blurring of vision, lightheadedness, nausea, SOB, and left-sided chest pain with return for re-evaluation. Pt treated for possible allergic reaction and concurrent EKG and blood work showed elevated troponin and transient ST elevation. Cardiology consulted and evaluated patient to have severe acute onset systolic heart failure, cardiogenic shock with pulmonary edema, Idiopathic fulminant myocarditis with myonecrosis, and hypoxic respiratory failure. Placed on furosemide, supplemental oxygen, and pending MRI.


VAERS ID: 1148316 (history)  
Form: Version 2.0  
Age: 19.0  
Sex: Male  
Location: Texas  
Vaccinated:2021-03-13
Onset:2021-03-14
   Days after vaccination:1
Submitted: 0000-00-00
Entered: 2021-03-30
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
COVID19: COVID19 (COVID19 (MODERNA)) / MODERNA 045A21A / 2 LA / IM

Administered by: Public       Purchased by: ?
Symptoms: Antinuclear antibody negative, Blood thyroid stimulating hormone decreased, Borrelia test, Brain natriuretic peptide increased, Chest pain, Condition aggravated, Coxsackie virus test, Cytomegalovirus test negative, Dizziness, Drug screen negative, Electrocardiogram abnormal, HIV test negative, Immunology test, Leukocytosis, Magnetic resonance imaging abnormal, Magnetic resonance imaging heart, Myocarditis, Parvovirus B19 test negative, Thrombocytosis, Thyroxine free normal, Treponema test negative, Tri-iodothyronine free normal, Troponin increased, Viral test negative
SMQs:, Cardiac failure (broad), Neuroleptic malignant syndrome (broad), Myocardial infarction (narrow), Anticholinergic syndrome (broad), Arrhythmia related investigations, signs and symptoms (broad), Pulmonary hypertension (broad), Gastrointestinal nonspecific symptoms and therapeutic procedures (broad), Cardiomyopathy (broad), Hypothyroidism (broad), Hyperthyroidism (broad), Vestibular disorders (broad), Drug reaction with eosinophilia and systemic symptoms syndrome (broad), Immune-mediated/autoimmune disorders (broad)

Life Threatening? No
Birth Defect? No
Died? No
Permanent Disability? No
Recovered? Yes
Office Visit? Yes
ER Visit? No
ER or Doctor Visit? Yes
Hospitalized? Yes, 7 days
   Extended hospital stay? No
Previous Vaccinations:
Other Medications: NONE
Current Illness: NONE
Preexisting Conditions: PREVIOUS HISTORY OF CHEST PAIN AND ELEVATED LIVER ENZYMES 3 YEARS AGO
Allergies: NONE
Diagnostic Lab Data: TROPONIN ON ADMISSION WAS 1500$g$g200s UDS NEG ANA, HIV, CMV, SYPHILLIS, VIRAL PANEL ALL NEG PARVO NEG COXSACKIE AND LYME PENDING TSH LOW, FREE T3 AND T4 NORMAL BNP 147$g140$g111 LEUKOCYTOSIS AND THROMBOCYTOSIS IMPROVED EKG ABNORMAL EF 65-69% MRI CONSISTENT WITH MYOCARDITIS
CDC Split Type:

Write-up: BEGAN FEELING CHEST PAIN AND LIGHTHEADEDNESS BEGINNING 3/14, THE DAY AFTER GETTING THE VACCINE. HE PRESENTED TO THE EMERGENCY ROOM ON 3/17 WITH WORSENING OF CP THAT WOULD NOT GET BETTER WITH NSAIDS, PAIN RADIATING DOWN LEFT ARM. TROPONINS NOTED TO BE ELEVATED, PT ADMITTED TO INPATIENT ROOM FOR CARE ON 3/17. TESTING DONE AND PT TREATED FOR MYOCARDITIS POSSIBLY SECONDARY TO COVID 19 VACCINATION. DC''D HOME ON 3/24 WITH LISINOPRIL AND PREDNISONE. ORDERS TO FOLLOW UP WITH DR.


VAERS ID: 1152205 (history)  
Form: Version 2.0  
Age: 55.0  
Sex: Female  
Location: Unknown  
Vaccinated:2021-03-22
Onset:2021-03-23
   Days after vaccination:1
Submitted: 0000-00-00
Entered: 2021-03-31
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
COVID19: COVID19 (COVID19 (PFIZER-BIONTECH)) / PFIZER/BIONTECH EP6955 / 1 LA / IM

Administered by: Unknown       Purchased by: ?
Symptoms: Acute myocardial infarction, Cardiogenic shock, Catheterisation cardiac normal, Chills, Diarrhoea, Endotracheal intubation, Intensive care, Myalgia, Myocarditis, Pain, Sedation, Ventricular arrhythmia
SMQs:, Torsade de pointes/QT prolongation (broad), Rhabdomyolysis/myopathy (broad), Cardiac failure (narrow), Angioedema (broad), Myocardial infarction (narrow), Anticholinergic syndrome (broad), Ventricular tachyarrhythmias (narrow), Shock-associated circulatory or cardiac conditions (excl torsade de pointes) (narrow), Pseudomembranous colitis (broad), Embolic and thrombotic events, arterial (narrow), Gastrointestinal nonspecific symptoms and therapeutic procedures (narrow), Cardiomyopathy (broad), Eosinophilic pneumonia (broad), Noninfectious diarrhoea (narrow), Respiratory failure (broad), Tendinopathies and ligament disorders (broad), Drug reaction with eosinophilia and systemic symptoms syndrome (broad), Immune-mediated/autoimmune disorders (broad)

Life Threatening? Yes
Birth Defect? No
Died? No
Permanent Disability? No
Recovered? No
Office Visit? Yes
ER Visit? No
ER or Doctor Visit? Yes
Hospitalized? Yes, 2 days
   Extended hospital stay? No
Previous Vaccinations:
Other Medications: amlodipine 10 cymbalta DR 60 mg estradiol 0.5 mg flonase nasal spray probiotic levothyroxine 50 mcg mometasone 0.1% lotion topiratmate Xr 200 mg eletriptan 40 mg advair HFA inhaler omeprazole 20 mg EC proair HFA inhaler garlic turmeric
Current Illness: None
Preexisting Conditions: atypical chest pain arthritis asthma celiac disease chronic kidney disease epilepsy (last sz 18 yrs ago) GERD migraine/headache TMJ
Allergies: None
Diagnostic Lab Data:
CDC Split Type:

Write-up: Patient received first dose of Pfizer COVID-19 vaccine on 3/22/21, the next day the patient reported feeling myalgia, diarrhea, and body aches and chills. The patient presented to the ED and was admitted with myocarditis and NSTEMI. Left heart cath did not show evidence of epicardial coronary artery disease. The patient was discharged from the hospital after receiving fluid resuscitation and supportive care. The patient returned to the ED with worsening myocarditis and was found to be in cardiogenic shock requiring vasopressor support. The patient developed VT storm and was intubated and sedated. The patient is currently in the ICU and remains intubated and sedated


VAERS ID: 1154298 (history)  
Form: Version 2.0  
Age: 20.0  
Sex: Male  
Location: Unknown  
Vaccinated:2021-03-24
Onset:2021-03-25
   Days after vaccination:1
Submitted: 0000-00-00
Entered: 2021-03-31
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
COVID19: COVID19 (COVID19 (MODERNA)) / MODERNA 001B21A / 2 LA / IM

Administered by: Military       Purchased by: ?
Symptoms: Blood test, Catheterisation cardiac normal, Chest pain, Computerised tomogram abnormal, Echocardiogram abnormal, Electrocardiogram ST segment depression, Electrocardiogram ST segment elevation, Myocarditis, Pericarditis, Troponin increased
SMQs:, Systemic lupus erythematosus (broad), Myocardial infarction (narrow), Gastrointestinal nonspecific symptoms and therapeutic procedures (broad), Cardiomyopathy (broad), Other ischaemic heart disease (broad), Chronic kidney disease (broad), Drug reaction with eosinophilia and systemic symptoms syndrome (broad), Hypokalaemia (broad), Immune-mediated/autoimmune disorders (broad)

Life Threatening? No
Birth Defect? No
Died? No
Permanent Disability? No
Recovered? No
Office Visit? Yes
ER Visit? No
ER or Doctor Visit? Yes
Hospitalized? Yes, ? days
   Extended hospital stay? No
Previous Vaccinations:
Other Medications: Patient was not taking any medications at the time of vaccination but was taking tylenol and naproxen after vaccination due to fever, chills, myalgias after vaccination
Current Illness: No illness, but had some orthopedic pain (achilles tendonitis)
Preexisting Conditions: None
Allergies: No known drug or food allergies.
Diagnostic Lab Data: As above, on the 27th he presented with chest pain. Had EKG, CT, blood work, and cardiac cath. EKG showed elevations on lateral leads with depression on anterior leads with elevated troponins. CT, Echo showed mild inflammation of the heart. Diagnosed with myocarditis/pericarditis
CDC Split Type:

Write-up: Patient is a 20 y/o Male received the MODERNA vaccine on 24 Mar. He started developing substernal chest pain the day after his vaccination. Presented to the clinic with worsening chest pain and was in severe pain upon presentation. ST elevations noted on lateral leads with depression in anterior leads with elevated troponins. Had CT, echo, and cath which showed mild inflammation and normal cardiac cath. Patient diagnosed with myocarditis.


VAERS ID: 1154628 (history)  
Form: Version 2.0  
Age: 58.0  
Sex: Female  
Location: Indiana  
Vaccinated:2021-03-25
Onset:2021-03-29
   Days after vaccination:4
Submitted: 0000-00-00
Entered: 2021-03-31
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
COVID19: COVID19 (COVID19 (PFIZER-BIONTECH)) / PFIZER/BIONTECH ER8730 / UNK - / IM

Administered by: Other       Purchased by: ?
Symptoms: Blood test abnormal, Bone pain, Catheterisation cardiac abnormal, Chest discomfort, Dizziness, Headache, Magnetic resonance imaging heart, Muscular weakness, Myalgia, Myocarditis, Pain in extremity, Stress cardiomyopathy, Troponin increased
SMQs:, Rhabdomyolysis/myopathy (broad), Anaphylactic reaction (broad), Peripheral neuropathy (broad), Myocardial infarction (narrow), Anticholinergic syndrome (broad), Embolic and thrombotic events, arterial (narrow), Guillain-Barre syndrome (broad), Noninfectious encephalopathy/delirium (broad), Cardiomyopathy (narrow), Eosinophilic pneumonia (broad), Other ischaemic heart disease (narrow), Vestibular disorders (broad), Osteonecrosis (broad), Tendinopathies and ligament disorders (broad), Drug reaction with eosinophilia and systemic symptoms syndrome (broad), Immune-mediated/autoimmune disorders (broad)

Life Threatening? Yes
Birth Defect? No
Died? No
Permanent Disability? No
Recovered? No
Office Visit? No
ER Visit? No
ER or Doctor Visit? Yes
Hospitalized? Yes, 3 days
   Extended hospital stay? No
Previous Vaccinations: 3/4/2021: sore arm after 1st COVID-10 vaccine dose; 3/25/2021: sore are, headache, muscle and bone aches for approx. 36 hours fo
Other Medications: OTC multi-vitamin, OTC multi-mineral, OTC Omega3 supplement, OTC glucosamine HCl/ginger/chondroitin/MSM, OTC magnesium citrate
Current Illness: none
Preexisting Conditions: none
Allergies: erythromucin
Diagnostic Lab Data: at least 2 blood tests on 3/29/2021 showed elevated troponin levels, additional blood tests were run 3/30/2021 & 3/31 2021, but results weren''t shared with patient heart catheterization (3/29/2021) cardiac MRI (3/30/2021)
CDC Split Type:

Write-up: Patient felt pressure on chest & weakness on inside of left are in the bicep area shortly after getting up at 6 am 3/29/2021. Slight light-headedness was felt shortly afterwards. Symptoms did not change after moving around & on the advice of patient''s insurance company''s Nurse Line, she went to the Emergency Room shortly after 7 am. Patient underwent a heart catheterization that day (3/29/2021) and a cardiac MRI the following day (3/30/2021). Cardiologist informed patient he suspected either Stress Cardiomyopathy or Myocarditis. Patient was discharged 3/31/2021 with 4 medications and follow-up appointments scheduled


VAERS ID: 1153962 (history)  
Form: Version 2.0  
Age:   
Sex: Male  
Location: Unknown  
Vaccinated:2021-03-12
Onset:2021-03-15
   Days after vaccination:3
Submitted: 0000-00-00
Entered: 2021-04-01
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
COVID19: COVID19 (COVID19 (MODERNA)) / MODERNA 038A21A / 1 - / OT

Administered by: Unknown       Purchased by: ?
Symptoms: Chest pain, Myocarditis, SARS-CoV-2 antibody test, SARS-CoV-2 test
SMQs:, Gastrointestinal nonspecific symptoms and therapeutic procedures (broad), Cardiomyopathy (broad), Drug reaction with eosinophilia and systemic symptoms syndrome (broad), Immune-mediated/autoimmune disorders (broad), COVID-19 (broad)

Life Threatening? No
Birth Defect? No
Died? No
Permanent Disability? No
Recovered? No
Office Visit? No
ER Visit? No
ER or Doctor Visit? No
Hospitalized? Yes, ? days
   Extended hospital stay? No
Previous Vaccinations:
Other Medications:
Current Illness:
Preexisting Conditions: Medical History/Concurrent Conditions: COVID-19 (Reporter reported that patient had COVID-19 in Mar 2020 was exposed and may have had it a second time on 11/2020); COVID-19
Allergies:
Diagnostic Lab Data: Test Name: COVID- 19 antibody; Test Result: Positive ; Result Unstructured Data: about 561; Test Date: 202003; Test Name: COVID-19 TEST; Test Result: Positive ; Result Unstructured Data: The patient had covid 3/2020 and was exposed and may have had it a second time on 11/2020
CDC Split Type: USMODERNATX, INC.MOD20210

Write-up: Acute myocarditis; Chest pain; A spontaneous report was received from a physician concerning (patient age: unknown) male patient who received Moderna''s COVID-19 vaccine (mRNA-1273) and experienced chest pain, acute myocarditis (myocarditis). The patient''s medical history included COVID-19 in Mar 2020 and was exposed and may have had it a second time in Nov 2020. Concomitant medications were not provided. On 12 Mar 2021, prior to the onset of the event, the patient received their first of two planned doses of mRNA-1273 (Lot number: 038A21A) intramuscularly for prophylaxis of COVID-19 infection. On 15 Mar 2021, the patient developed chest pain and was admitted to the hospital. The patient underwent cardiac catheterization, echocardiogram and cardiac MRI (magnetic resonance imaging). Results of the echocardiogram and cardiac MRI were not provided. The final diagnosis of the patient was acute myocarditis. COVID antibodies were positive, about 561 for the patient. The events chest pain and acute myocarditis lead to hospitalization. Treatment activities for the events were unknown. Action taken with mRNA-1273 in response to the events was unknown. The outcome of events, experienced chest pain and acute myocarditis, was unknown.; Reporter''s Comments: Based on the current available information and temporal association between the use of the product and the start date of the events, a causal relationship cannot be excluded.


VAERS ID: 1157566 (history)  
Form: Version 2.0  
Age: 62.0  
Sex: Female  
Location: Tennessee  
Vaccinated:2020-12-23
Onset:2021-03-07
   Days after vaccination:74
Submitted: 0000-00-00
Entered: 2021-04-01
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
COVID19: COVID19 (COVID19 (MODERNA)) / MODERNA 039K20A / 1 - / OT

Administered by: Unknown       Purchased by: ?
Symptoms: Antibody test, Myocarditis, Vaccination complication
SMQs:, Cardiomyopathy (broad), Drug reaction with eosinophilia and systemic symptoms syndrome (broad), Immune-mediated/autoimmune disorders (broad)

Life Threatening? No
Birth Defect? No
Died? No
Permanent Disability? No
Recovered? No
Office Visit? No
ER Visit? No
ER or Doctor Visit? No
Hospitalized? No
Previous Vaccinations:
Other Medications: ASPIRIN 81; ATORVASTATIN; ESCITALOPRAM
Current Illness: Blood donor (Also, was a blood donor all last year)
Preexisting Conditions:
Allergies:
Diagnostic Lab Data: Test Date: 2020; Test Name: Antibody testing; Test Result: Negative ; Result Unstructured Data: Negative; Test Date: 20210307; Test Name: Antibody testing; Test Result: Negative ; Result Unstructured Data: Negative
CDC Split Type: USMODERNATX, INC.MOD20210

Write-up: Myocarditis; Started having symptoms and typical symptoms; A spontaneous report was reported from a nurse (patient), concerning herself, a 62 years-old female patient, unknown race and ethnicity, was administered Moderna''s COVID-19 vaccine (mRNA-1273), and experienced myocarditis, and started having symptoms and typical symptoms (vaccination complication). The patient''s current condition included blood donor. Concomitant medications reported included acetylsalicylic acid, atorvastatin, and escitalopram. On 23 Dec 2020, the patient received her first of two planned doses of mRNA-1273 (batch number: 039K20A) intramuscularly for prophylaxis of COVID-19 infection. On 20 Jan 2021, prior to the onset of the events, the patient received her second of two planned doses of mRNA-1273 (batch number: 027L20A) intramuscularly for prophylaxis of COVID-19 infection. The patient had nothing after the first dose and typical symptoms after the second dose. She started having symptoms on 07 Mar 2021. The patient was healthy and doesn''t have any coronary disease. This was a red herring and stated that she was a blood donor and gave blood on Sunday, 07 Mar 2021. That''s, the same day, the symptoms started. Also, the patient was a blood donor all last year. All the antibody tests were negative for last year and including the recent 07 Mar 2021 donation. This was outside the window of expected reactions, but she''s been diagnosed with myocarditis, effective last week on 11 Mar 2021. The patient reported that the doctor started her on metoprolol tartrate 25 mg twice daily, which was started on 14 Mar 2021. Action taken with second dose of mRNA-1273 in response to the event was not applicable. The outcome of the events, myocarditis, and started having symptoms and typical symptoms were considered as unknown.; Sender''s Comments: Based on the current available information and temporal association between the use of the product and the start date of the events, a causal relationship cannot be excluded. However, Further information is requested.


VAERS ID: 1162020 (history)  
Form: Version 2.0  
Age: 62.0  
Sex: Female  
Location: Puerto Rico  
Vaccinated:2021-03-16
Onset:2021-03-01
Submitted: 0000-00-00
Entered: 2021-04-02
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
COVID19: COVID19 (COVID19 (MODERNA)) / MODERNA 001B21A / 1 - / OT

Administered by: Unknown       Purchased by: ?
Symptoms: Cardiac disorder, Chest pain, Fatigue, Headache, Myocarditis, Pyrexia, Renal pain
SMQs:, Neuroleptic malignant syndrome (broad), Anticholinergic syndrome (broad), Gastrointestinal nonspecific symptoms and therapeutic procedures (broad), Cardiomyopathy (broad), Drug reaction with eosinophilia and systemic symptoms syndrome (broad), Immune-mediated/autoimmune disorders (broad)

Life Threatening? No
Birth Defect? No
Died? No
Permanent Disability? No
Recovered? Yes
Office Visit? No
ER Visit? No
ER or Doctor Visit? No
Hospitalized? No
Previous Vaccinations:
Other Medications: LEVOTHYROXINE; METFORMIN; GLIMEPIRIDE; SIMVASTATIN; LOSARTAN
Current Illness:
Preexisting Conditions: Medical History/Concurrent Conditions: No adverse event (No medical history reported.)
Allergies:
Diagnostic Lab Data:
CDC Split Type: USMODERNATX, INC.MOD20210

Write-up: A spontaneous report was received from a consumer concerning a 62-year-old, female patient who felt like a needle in her kidney/renal pain, feve/pyrexiar, fatigue, tiredness/fatigue, chest pain, upset heart/cardiac disorder, headache and inflammation of heart muscle/myocarditis. The patient''s medical history was not provided. Products known to have been used by the patient, within two weeks prior to the event, included levothyroxine, metformin, glimepiride, simvastatin, losartan. On 16 Mar 2021, prior to the onset of the symptoms, the patient received the first of two planned doses of mRNA-1273 (Batch number: 001B21A) intramuscularly for prophylaxis of COVID-19 infection. On 16 Mar 2021, 5 minutes later she experienced felt like a needle in her kidney. On 17 Mar 2021, she had fever. On an unknown date in Mar 2021, she had fatigue and tiredness. On 20 Dec 2021, she had chest pain and upset heart. On 21 Mar 2021, she had a headache and fever. On 22 Mar 2021 she had chest pain and went to the doctor and was diagnosed inflammation of the heart muscle. The event inflammation of the heart muscle was assessed medically significant. Treatment for the event included acetaminophen. Action taken with mRNA-1273 in response to the events was not provided. The events felt like a needle in her kidney was resolved on 16 Mar 2021. The events fever and headache were resolved on 21 Mar 2021. The outcome of the evens fatigue, tiredness, chest pain, upset heart and inflammation of heart muscle were unknown.; Reporter''s Comments: Based on the current available information and temporal association between the use of the product and the start date of the events, a causal relationship cannot be excluded.


VAERS ID: 1164186 (history)  
Form: Version 2.0  
Age: 37.0  
Sex: Male  
Location: Massachusetts  
Vaccinated:2021-03-20
Onset:2021-03-22
   Days after vaccination:2
Submitted: 0000-00-00
Entered: 2021-04-03
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
COVID19: COVID19 (COVID19 (PFIZER-BIONTECH)) / PFIZER/BIONTECH EN6203 / 1 LA / SYR
COVID19: COVID19 (COVID19 (PFIZER-BIONTECH)) / PFIZER/BIONTECH ER2613 / 2 LA / SYR

Administered by: Pharmacy       Purchased by: ?
Symptoms: Autoimmune disorder, Catheterisation cardiac, Chest pain, Chills, Condition aggravated, Feeling abnormal, Hyperhidrosis, Magnetic resonance imaging abnormal, Magnetic resonance imaging heart, Myocardial infarction, Myocarditis, Oropharyngeal pain, Pain, Poor quality sleep, Sleep disorder, Throat irritation, Troponin
SMQs:, Neuroleptic malignant syndrome (broad), Myocardial infarction (narrow), Dementia (broad), Embolic and thrombotic events, arterial (narrow), Oropharyngeal conditions (excl neoplasms, infections and allergies) (narrow), Gastrointestinal nonspecific symptoms and therapeutic procedures (broad), Cardiomyopathy (broad), Depression (excl suicide and self injury) (broad), Drug reaction with eosinophilia and systemic symptoms syndrome (broad), Hypoglycaemia (broad), Immune-mediated/autoimmune disorders (narrow)

Life Threatening? Yes
Birth Defect? No
Died? No
Permanent Disability? No
Recovered? No
Office Visit? Yes
ER Visit? No
ER or Doctor Visit? Yes
Hospitalized? Yes, 3 days
   Extended hospital stay? No
Previous Vaccinations:
Other Medications: none
Current Illness: none
Preexisting Conditions: none
Allergies: none
Diagnostic Lab Data: cardiac catherization - done on March 23rd cardiac MRI - done on March 25th lots of medications given to me
CDC Split Type:

Write-up: I received my second shot of the Pfizer coronavirus vaccine on Saturday, March 20th at noon. Saturday at midnight, I woke up in full body sweats and aches. I took two ibuprofen and tried to go back to sleep, but I would toss and turn in full body sweats and aches for the next 8 hours. I took another 2 ibuprofen around 400am. Sunday morning I woke up feeling OK, not great, but OK. Sunday night ? it was very strange ? the full body chills and aches came back. Not as bad as Saturday night, but they returned nevertheless. I had another restless night of sleep, and I took another two rounds of ibuprofen to try and help me sleep. Monday I woke up feeling OK again. Monday evening, around 8:00pm, I could feel the full body chills and aches coming back again, creeping up slightly. This time, I also felt a mild burning in my upper chest and throat. I went to bed around 8:00pm, then woke up at 9:00pm, this time in a lot of pain. It felt like burning and a stabbing sensation in my throat and upper chest. I took some ibuprofen, and tried to fall asleep. I tossed and turned in agony for the next few hours, apparently falling asleep at some point around 1:00am. At 2:00am I woke up in severe pain again. It was very bad, like an 8 out of a 10. It felt like a burning and stabbing sensation in my lower throat and upper chest. I had my wife call 911, and I was brought to hospital in an ambulance. I would stay in the hospital for the next 3 days, getting discharged Thursday at around 5:00pm. I had peak troponin levels of 5, so I basically had a moderate heart attack. I had a cardiac catherization procedure done, as well as a cardiac MRI. The cardiac catherization procedure showed I had no blockages at all in my arteries. The cardiologists diagnosed me with myocarditis. The cardiologists told me they believe the vaccine triggered a heavy response from my auto immune system. The response from my auto immune system in turn caused my heart to become inflamed, giving me myocarditis. It was a horrible experience, and my doctors are convinced that it was brought on by the second coronavirus vaccine shot that I received.


VAERS ID: 1167252 (history)  
Form: Version 2.0  
Age: 23.0  
Sex: Male  
Location: Unknown  
Vaccinated:2021-03-26
Onset:2021-03-30
   Days after vaccination:4
Submitted: 0000-00-00
Entered: 2021-04-04
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
COVID19: COVID19 (COVID19 (MODERNA)) / MODERNA 046A21A / 2 LA / IM

Administered by: Military       Purchased by: ?
Symptoms: Catheterisation cardiac, Chest X-ray normal, Chest pain, Electrocardiogram, Electrocardiogram ST segment abnormal, Myocarditis, Pericarditis, Troponin I increased
SMQs:, Systemic lupus erythematosus (broad), Myocardial infarction (narrow), Gastrointestinal nonspecific symptoms and therapeutic procedures (broad), Cardiomyopathy (broad), Chronic kidney disease (broad), Drug reaction with eosinophilia and systemic symptoms syndrome (broad), Immune-mediated/autoimmune disorders (broad)

Life Threatening? No
Birth Defect? No
Died? No
Permanent Disability? No
Recovered? No
Office Visit? Yes
ER Visit? No
ER or Doctor Visit? Yes
Hospitalized? Yes, 4 days
   Extended hospital stay? No
Previous Vaccinations:
Other Medications: acetaminophen
Current Illness: none
Preexisting Conditions: SCT
Allergies: none
Diagnostic Lab Data: Troponin I: 2.6 CXR: negative EKG: non-specific ST abnormalities V3/V4/V5
CDC Split Type:

Write-up: Chest pain 3 days after shot. Troponin I was elevated, referred patient to cardiology. Had cardiac catheter, suspected mild myocarditis. Initially treated with NSAIDs and colchicine during encounter for suspected pericarditis since troponin came back later that day (had to be shipped to hospital). Now treatment includes no strenuous activity for 6 weeks, no travel for 3 months. Follow-up with cardiology in 3 month for reevaluation.


Result pages: prev   1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17   next

New Search

Link To This Search Result:

https://medalerts.org/vaersdb/findfield.php?EVENTS=ON&PAGENO=8&SYMPTOMS=Myocarditis_%2810028606%29&VAX=COVID19&VAXTYPES=COVID-19


Copyright © 2021 National Vaccine Information Center. All rights reserved.
21525 Ridgetop Circle, Suite 100, Sterling, VA 20166